Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Lucy Clare Padget has worked on the following 3 EPO patent applications which have been published in the last five years:

EP11746295

N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS

IPC classification:
A61K 31/445, A61P 35/00, A61P 35/02, C07D 211/22
Applicant:
AstraZeneca AB
Agent:
Multiple attorneys, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Agent:
Lucy Clare Padget, AstraZeneca UK Limited
Status:
The patent has been granted
EP14710620

QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR

IPC classification:
A61K 31/495, A61K 31/505, C07D 403/12
Applicant:
AstraZeneca AB
Agent:
Multiple attorneys, Kilburn & Strode LLP
Agent:
Lucy Clare Padget, AstraZeneca UK Limited
Status:
The patent has been granted
EP11783835

NEW PROCESS FOR THE PREPARATION OF ARYL SUBSTITUTED OLEFINIC AMINES

IPC classification:
C07C 29/40, C07C 211/21, C07C 231/14, C07D 213/65
Applicant:
AstraZeneca AB
Agent:
Charlotte Waveney Crowhurst, Potter Clarkson LLP
Agent:
Lucy Clare Padget, AstraZeneca AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature